Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Medically reviewed by Mary Choy, PharmD Some people who take Ozempic (semaglutide)—a drug for diabetes management and weight ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.

Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

A pill that mimics the effect of a gastric ... Its manufacturers say it may have advantages over weight-loss injections such as Ozempic and Mounjaro, including having fewer side effects and ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

The Danish drugmaker, which makes Ozempic and Wegovy ... Eli Lilly is developing new weight-loss drugs, including a daily pill, that are expected to set up years of blockbuster sales for the ...